Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL) - Tsai, T F; Ho, J C; Song, M; PEARL Investigators (J Dermatol Sci, 2011)